Regulation of immune reactivity and tolerance by antigen migration and localization: with particular reference to allo- and xenotransplantation.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3154794)

Published in Transplant Proc on June 01, 1999

Authors

T E Starzl1, N Murase, A W Thomson, M Trucco, A Rao

Author Affiliations

1: Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA.

Articles cited by this

Actively acquired tolerance of foreign cells. Nature (1953) 19.82

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. Surg Gynecol Obstet (1963) 8.04

FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71

Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell (1991) 6.49

Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell (1990) 6.33

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Immunology taught by viruses. Science (1996) 4.82

Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med (1990) 3.73

Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71

Drug-induced immunological tolerance. Nature (1959) 3.68

A biological role for the major histocompatibility antigens. Lancet (1975) 3.40

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol (1983) 3.32

On immunological memory. Annu Rev Immunol (1996) 3.21

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev (1997) 2.58

Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29

Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20

Homograft sensitivity. An expression of the immunologic origins and consequences of individuality. Physiol Rev (1959) 2.14

Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol Today (1997) 2.05

Immunization with skin isografts taken from tolerant mice. Science (1967) 2.05

Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81

Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science (1976) 1.80

The discovery of MHC restriction. Immunol Today (1997) 1.76

Pathogenesis of a local graft versus host reaction: immunogenicity of circulating host leukocytes. Science (1968) 1.69

High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65

HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM). Br Med J (1963) 1.59

Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. J Immunol (1993) 1.55

Peripheral T cell tolerance. Annu Rev Immunol (1992) 1.47

Chimerism and transplantation tolerance: cause and effect. Immunol Today (1996) 1.35

Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity. J Exp Med (1982) 1.21

Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci U S A (1996) 1.12

The wisdom of hindsight. Annu Rev Immunol (1994) 1.10

Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal. Proc Natl Acad Sci U S A (1997) 1.08

Microchimerism: inaccurate literature citations. Transplantation (1996) 0.80

Will xenotransplantation ever be feasible? J Am Coll Surg (1998) 0.78

Articles by these authors

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity (1998) 5.38

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature (1993) 4.26

Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science (1999) 4.20

Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol (2001) 4.09

Partners in transcription: NFAT and AP-1. Oncogene (2001) 3.83

Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature (1998) 3.71

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell (2000) 3.44

Nuclear factor of activated T cells contains Fos and Jun. Nature (1992) 3.43

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Transcriptional regulation of the IL-2 gene. Curr Opin Immunol (1995) 3.14

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J Cell Biol (1997) 2.92

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

FK 506: an immunosuppressant for the 1990s? Lancet (1991) 2.80

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75

Detection of Y chromosome sequences in Turner's syndrome by Southern blot analysis of amplified DNA. Lancet (1993) 2.65

An enhanced immune response in mice lacking the transcription factor NFAT1. Science (1996) 2.55

Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol (1999) 2.48

Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48

NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc Natl Acad Sci U S A (1999) 2.48

Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol Cell (1998) 2.44

Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature (1997) 2.41

Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature (1994) 2.25

Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24

FK-506--how much potential? Immunol Today (1989) 2.20

Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A (1988) 2.19

Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J (2000) 2.14

Analysis of the AP-1 sites in the IL-2 promoter. J Immunol (1992) 2.14

Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity (2000) 2.13

Calcineurin: from structure to function. Curr Top Cell Regul (2000) 2.10

Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol (1996) 2.03

CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cell Motil Cytoskeleton (1993) 1.99

Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology (1983) 1.99

Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol (2001) 1.95

Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity (2001) 1.94

Postsynaptically silent synapses in single neuron cultures. Neuron (1998) 1.94

NKR-P1, a signal transduction molecule on natural killer cells. Science (1990) 1.94

Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation (1993) 1.94

Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J Exp Med (1993) 1.93

Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem (1996) 1.91

Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med (1995) 1.88

Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86

NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J Biol Chem (1993) 1.84

Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83

Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81

Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity (2000) 1.79

Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol (1991) 1.78

Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow "focal" ablation. Circulation (2001) 1.73

Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck (1997) 1.71

A similar DNA-binding motif in NFAT family proteins and the Rel homology region. J Biol Chem (1995) 1.70

Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant (2009) 1.69

Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. Transplantation (1996) 1.65

Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg Med Chem Lett (2001) 1.64

Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology (1999) 1.64

Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation (1995) 1.63

Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol Cell Biol (1996) 1.61

Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet (1992) 1.61

Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol (2000) 1.60

Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J Exp Med (1998) 1.58

Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J Biol Chem (1994) 1.56

A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J (1994) 1.56

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ (2004) 1.54

Oxidative stress and antioxidants in epilepsy. Clin Chim Acta (2001) 1.53

Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest (1999) 1.53

Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol (1996) 1.53

Drug development and testing in relation to cell migration and chimerism. Transplant Proc (1993) 1.52

The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription. J Biol Chem (1994) 1.52

Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52

Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation (1995) 1.51

A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50

Noninvasive measures of oxidative metabolism on working human muscles by near-infrared spectroscopy. J Appl Physiol (1985) (1996) 1.50

The effect of FK-506 on hyperacute rejection in presensitized rats. Transplant Proc (1987) 1.49

Osmophobia in migraine and tension-type headache and its clinical features in patients with migraine. Cephalalgia (2007) 1.49

Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity (1997) 1.49